Cargando…

A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19

Laboratory diagnosis of the COVID-19 relies on RT-PCR to amplify specific fragments of SARS-CoV-2 genome. However, serological tests are required to determine the immune response elicited after infection. Here, we analyzed convalescent sera collected from positive individuals by RT-PCR to SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guevara, Ángel, Vivero, Sandra, Nipaz, Victoria, Guaraca, Victor, Coloma, Josefina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045656/ https://www.ncbi.nlm.nih.gov/pubmed/33630751 http://dx.doi.org/10.4269/ajtmh.20-1420

Ejemplares similares

Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response
por: Mao, Ling, et al.
Publicado: (2022)

SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis
por: Márquez, Sully, et al.
Publicado: (2021)

Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019
por: Shaffer, Jeffrey G., et al.
Publicado: (2021)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

Alternative RNA extraction-free techniques for the real-time RT-PCR detection of SARS-CoV-2 in nasopharyngeal swab and sputum samples
por: Villota, Stephany D., et al.
Publicado: (2021)

Elevated Humoral Immune Response to SARS-CoV-2 at High Altitudes Revealed by an Anti-RBD “In-House” ELISA
por: Tomas-Grau, Rodrigo Hernán, et al.
Publicado: (2021)

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
por: Pi-Estopiñan, Franciscary, et al.
Publicado: (2022)

Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Bacterial identification of the vaginal microbiota in Ecuadorian pregnant teenagers: an exploratory analysis
por: Salinas, Ana María, et al.
Publicado: (2018)

Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy
por: Triebwasser, Jourdan E., et al.
Publicado: (2022)

Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy
por: Triebwasser, Jourdan E., et al.
Publicado: (2022)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings
por: Benabdessalem, Chaouki, et al.
Publicado: (2023)

Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas
por: Nascimento, Eduardo J. M., et al.
Publicado: (2019)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
por: Fu, Wenyu, et al.
Publicado: (2020)

Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins
por: Yilmaz, Aysun, et al.
Publicado: (2022)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Development of a Multispecies Double-Antigen Sandwich ELISA Using N and RBD Proteins to Detect Antibodies against SARS-CoV-2
por: Cordero-Ortiz, Maritza, et al.
Publicado: (2023)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Psychometric properties and factorial structure of the Spanish version of the psychological capital scale in Ecuadorian university students
por: López-Guerra, Víctor, et al.
Publicado: (2023)

Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
por: Meyers, Eline, et al.
Publicado: (2022)

Salmonella dublin in Danish Dairy Herds: Frequency of Change to Positive Serological Status in Bulk Tank Milk ELISA in Relation to Serostatus of Neighbouring Farms
por: Wedderkopp, A, et al.
Publicado: (2001)

The serostatus approach to fighting COVID-19
por: Kenyon, Chris
Publicado: (2020)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds
por: Padoan, Andrea, et al.
Publicado: (2022)

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
por: Aguilar, Ruth, et al.
Publicado: (2023)

An Archaeometric Characterization of Ecuadorian Pottery
por: Sánchez-Polo, Alejandra, et al.
Publicado: (2019)

Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic
por: Raffi, François, et al.
Publicado: (2023)

Field evaluation of rapid diagnostic tests to determine dengue serostatus in Timor-Leste
por: Arkell, Paul, et al.
Publicado: (2022)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
por: Echeverría, Gustavo, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
por: Sepúlveda, Maria, et al.
Publicado: (2016)

The impact of an unknown HIV serostatus on inpatient mortality
por: Moodley, Yoshan
Publicado: (2017)

The importance of serostatus awareness in arresting the spread of HIV
por: Mayer, Kenneth H, et al.
Publicado: (2018)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBD(N318-V510)) Expressed in Escherichia coli
por: Márquez-Ipiña, Alan Roberto, et al.
Publicado: (2021)

Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study
por: Lopez, Anna Lena, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique
por: Benoni, Roberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_02k9jb81489usqbicutjlk6hlu